Crescent Capital BDC (CCAP)
(Delayed Data from NSDQ)
$18.77 USD
-0.12 (-0.64%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $18.76 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.77 USD
-0.12 (-0.64%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $18.76 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
Zacks News
Why Crescent Capital BDC (CCAP) Outpaced the Stock Market Today
by Zacks Equity Research
Crescent Capital BDC (CCAP) closed at $15.81 in the latest trading session, marking a +1.41% move from the prior day.
Crescent Capital BDC (CCAP) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
Crescent Capital BDC (CCAP) reachead $16.87 at the closing of the latest trading day, reflecting a -0.24% change compared to its last close.
Crescent Capital BDC (CCAP) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
Crescent Capital BDC (CCAP) closed the most recent trading day at $16.60, moving +0.06% from the previous trading session.
Crescent Capital BDC (CCAP) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Crescent Capital BDC (CCAP) closed the most recent trading day at $16.36, moving -1.56% from the previous trading session.
Are Finance Stocks Lagging Crescent Capital BDC (CCAP) This Year?
by Zacks Equity Research
Here is how Crescent Capital BDC (CCAP) and Axa Sa (AXAHY) have performed compared to their sector so far this year.
Crescent Capital BDC (CCAP) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Crescent Capital BDC (CCAP) closed at $17.13, marking a -1.72% move from the previous day.
Crescent Capital BDC (CCAP) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Crescent Capital BDC (CCAP) closed at $17.20, marking a +1.18% move from the previous day.
Crescent Capital BDC (CCAP) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Crescent Capital BDC (CCAP) closed the most recent trading day at $16.51, moving +1.04% from the previous trading session.
Best Momentum Stocks to Buy for September 7th
by Zacks Equity Research
CCAP and PKST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 7, 2023.
New Strong Buy Stocks for September 7th
by Zacks Equity Research
CCAP, CR, STIX, BMI and ON have been added to the Zacks Rank #1 (Strong Buy) List on September 7, 2023.
Best Income Stocks to Buy for September 7th
by Zacks Equity Research
CCAP and NVT made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 7, 2023.
Are Finance Stocks Lagging Crescent Capital BDC (CCAP) This Year?
by Zacks Equity Research
Here is how Crescent Capital BDC (CCAP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Beat the Market Like Zacks: Hubbell, Adobe, Nikola in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
The Zacks Analyst Blog Highlights Getty Realty, Trinity Capital, Crescent Capital, Golub Capital and Runway Growth Finance
by Zacks Equity Research
Getty Realty, Trinity Capital, Crescent Capital, Golub Capital and Runway Growth Finance are included in this Analyst Blog.
5 Ultra-Safe Stocks to Counter a Choppy Wall Street
by Tirthankar Chakraborty
With things looking murkier this August, invest in stocks like Getty Realty (GTY), Trinity Capital (TRIN), Crescent Capital (CCAP), Golub Capital (GBDC) and Runway Growth Finance (RWAY) for a steady income.
Best Momentum Stocks to Buy for August 17th
by Zacks Equity Research
STLA, GO and CCAP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 17, 2023.
Crescent Capital BDC (CCAP) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Crescent Capital BDC (CCAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
The Zacks Analyst Blog Highlights Runway Growth Finance, Crescent Capital, Getty Realty and Cogent Communications
by Zacks Equity Research
Runway Growth Finance, Crescent Capital, Getty Realty and Cogent Communications are included in this Analyst Blog.
4 Safe Picks as Things Look Dicey for Wall Street This August
by Tirthankar Chakraborty
Since August is living up to its reputation of being notorious, invest in safe stocks such as Runway Growth Finance (RWAY), Crescent Capital (CCAP), Getty Realty (GTY) and Cogent Communications (CCOI).
Crescent Capital BDC (CCAP) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of 3.70% and 2.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
WhiteHorse Finance (WHF) Meets Q2 Earnings Estimates
by Zacks Equity Research
WhiteHorse (WHF) delivered earnings and revenue surprises of 0% and 0.99%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Crescent Capital (CCAP) in Q2 Earnings?
by Zacks Equity Research
Improvement in interest income on higher rates is likely to have supported Crescent Capital's (CCAP) Q2 earnings.
Main Street Capital (MAIN) Meets Q2 Earnings Estimates
by Zacks Equity Research
Main Street Capital (MAIN) delivered earnings and revenue surprises of 0% and 6.29%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Business Development Companies in Solid Shape: 3 Stocks to Buy
by Sanghamitra Saha
With rates rising, the regional banking crisis bothering the lending market and the U.S. economy chugging along, business development companies such as Saratoga Investment (SAR), Crescent Capital BDC (CCAP) and Main Street Capital (MAIN) have every reason to outperform.
Time to Buy Red-Hot Business Development ETFs?
by Sanghamitra Saha
With rates rising, the regional banking crisis bothering the lending market and the U.S. economy chugging along, business development companies have every reason to outperform.